Applying artificial intelligence to cardiovascular ultrasound imaging, Bay Labs works inthe space of diagnosis and management of heart disease. Organized around improving access, value, and quality to medical imaging, the effort is to promote and advance healthcare in both the developed and developing world, improving lives through better diagnosis and treatment of heart disease. The assembled team includes experts in machine learning, visual neuroscience, robotics, physics, and cardiology. In June 2018 the firm's EchoMD AutoEF software received FDA clearance for fully automated AI echocardiogram analysis
